BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $826 Price Target
Benzinga Newsdesk 41 minutes ago
Analyst RatingsNewsReiterationPrice Target
BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $826 price target.
BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $826 price target.